A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease
1999 ◽
Vol 20
(1)
◽
pp. 11-19
◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 12
(1)
◽
pp. 48-54
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):